[An economic evaluation of different treatments for HBeAg-positive chronic hepatitis B in China]. [electronic resource]
- Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology Jun 2007
- 431-6 p. digital
Adenine--analogs & derivatives Antiviral Agents--economics Cost-Benefit Analysis--economics Female Hepatitis B e Antigens--blood Hepatitis B, Chronic--blood Humans Lamivudine--economics Male Organophosphonates--economics Quality-Adjusted Life Years Treatment Outcome